enVVeno Medical (NVNO) Cash & Equivalents (2017 - 2026)

enVVeno Medical's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 11.58% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 11.58% YoY), while the FY2025 annual figure was $3.1 million, up 74.74% from the prior year.
• Cash & Equivalents was $2.6 million for Q1 2026 at enVVeno Medical, down from $3.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $51.3 million in Q1 2022 to a low of $1.5 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $8.9 million across 5 years, with a median of $3.1 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents slumped 95.0% in 2022, then surged 262.21% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $4.6 million in 2022, then slipped by 20.53% to $3.6 million in 2023, then slumped by 51.55% to $1.8 million in 2024, then soared by 74.74% to $3.1 million in 2025, then decreased by 15.27% to $2.6 million in 2026.
• The last three Cash & Equivalents figures came in at $2.6 million (Q1 2026), $3.1 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.